Literature DB >> 26906712

Dipeptidyl peptidase-4 activity might be a link between tumour necrosis factor alpha and insulin resistance in type 1 diabetes.

Lea Duvnjak1,2, Kristina Blaslov3, Matea Nikolac Perković4, Jadranka Knežević Ćuća1.   

Abstract

Tumour necrosis factor alpha (TNF α) leads to β cell damage in type 1 diabetes (T1DM) but also causes insulin resistance (IR). It modulates dipeptidyl peptidase-4 (DPP-4) activity, adipokine linked with both IR and T1DM. We were interested if there is an association of TNF α in conjunction with DPP-4 and IR in T1DM. DPP-4 activity, TNF α concentration measurements, and insulin sensitivity calculation using estimated glucose disposal rate (eGDR) equation were performed in 70 T1DM patients. They were divided into two groups according to eGDR median. The group with higher IR had higher value of DPP-4 activity (27.57 ± 1.77 vs. 18.33 ± 1.14, p < 0.001) and TNF α concentration (12.91 ± 0.83 vs. 6.72 ± 0.36, p < 0.001). TNF α concentration and DPP-4 activity negatively correlated with eGDR (r = -0.616, p < 0.001 and r = -0.643, p < 0.001) while correlating positively with each other (r = 0.422; p = 0.001). The linear regression showed that eGDR decreases for 0.166 mg kg(-1) min(-1) by TNF α concentration increase of 1 pg/mL (p < 0.001) and for 0.090 mg kg(-1) min(-1) by DPP-4 activity increase of 1 U/L (p = 0.001) when adjusted for age, gender disease duration, glycated haemoglobin, body mass index and waist-to-hip ratio. eGDR decreased by additional 0.60 mg kg(-1) min(-1) (B = -0.150, p < 0.001) when DPP-4 activity was additionally adjusted for TNF α. TNF α concentration is associated with IR, correlates with its severity and increases the drop in insulin sensitivity modulated by DPP-4 activity. Whether TNF α involvement in the insulin signalling pathway is mediated by DPP-4 activity needs to be further evaluated.

Entities:  

Keywords:  Dipeptidyl peptidase-4; Insulin sensitivity; Tumour necrosis factor alpha; Type 1 diabetes

Mesh:

Substances:

Year:  2016        PMID: 26906712     DOI: 10.1007/s12020-016-0899-4

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  27 in total

Review 1.  Insulin resistance is not necessarily an essential component of type 2 diabetes.

Authors:  J E Gerich
Journal:  J Clin Endocrinol Metab       Date:  2000-06       Impact factor: 5.958

2.  Can clinical factors estimate insulin resistance in type 1 diabetes?

Authors:  K V Williams; J R Erbey; D Becker; S Arslanian; T J Orchard
Journal:  Diabetes       Date:  2000-04       Impact factor: 9.461

3.  Relation between plasma tumor necrosis factor-alpha and insulin sensitivity in elderly men with non-insulin-dependent diabetes mellitus.

Authors:  J Nilsson; S Jovinge; A Niemann; R Reneland; H Lithell
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-08       Impact factor: 8.311

4.  Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients.

Authors:  Y Miyazaki; R Pipek; L J Mandarino; Ralph A DeFronzo
Journal:  Int J Obes Relat Metab Disord       Date:  2003-01

Review 5.  Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?

Authors:  Roger Yazbeck; Gordon S Howarth; Catherine A Abbott
Journal:  Trends Pharmacol Sci       Date:  2009-11       Impact factor: 14.819

6.  Serum dipeptidyl peptidase-4 activity in insulin resistant patients with non-alcoholic fatty liver disease: a novel liver disease biomarker.

Authors:  Gábor Firneisz; Tímea Varga; Gabriella Lengyel; János Fehér; Dóra Ghyczy; Barna Wichmann; László Selmeci; Zsolt Tulassay; Károly Rácz; Anikó Somogyi
Journal:  PLoS One       Date:  2010-08-18       Impact factor: 3.240

Review 7.  Insulin resistance associated to obesity: the link TNF-alpha.

Authors:  Iria Nieto-Vazquez; Sonia Fernández-Veledo; David K Krämer; Rocio Vila-Bedmar; Lucia Garcia-Guerra; Margarita Lorenzo
Journal:  Arch Physiol Biochem       Date:  2008-07       Impact factor: 4.076

8.  Impaired Akt phosphorylation in insulin-resistant human muscle is accompanied by selective and heterogeneous downstream defects.

Authors:  K T Tonks; Y Ng; S Miller; A C F Coster; D Samocha-Bonet; T J Iseli; A Xu; E Patrick; J Y H Yang; J R Junutula; Z Modrusan; G Kolumam; J Stöckli; D J Chisholm; D E James; J R Greenfield
Journal:  Diabetologia       Date:  2013-01-24       Impact factor: 10.122

9.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.

Authors:  G S Hotamisligil; N S Shargill; B M Spiegelman
Journal:  Science       Date:  1993-01-01       Impact factor: 47.728

10.  Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome.

Authors:  Daniela Lamers; Susanne Famulla; Nina Wronkowitz; Sonja Hartwig; Stefan Lehr; D Margriet Ouwens; Kristin Eckardt; Jean M Kaufman; Mikael Ryden; Stefan Müller; Franz-Georg Hanisch; Johannes Ruige; Peter Arner; Henrike Sell; Juergen Eckel
Journal:  Diabetes       Date:  2011-05-18       Impact factor: 9.461

View more
  1 in total

Review 1.  Role of Incretin Axis in Inflammatory Bowel Disease.

Authors:  Lihua Duan; Xiaoquan Rao; Zachary Braunstein; Amelia C Toomey; Jixin Zhong
Journal:  Front Immunol       Date:  2017-12-06       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.